Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Transplant success has improved with better immunosuppressive drugs and donor matching.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

The study found that diseases can be grouped by symptoms and that the accuracy of predicting disease-related genes varies with the data source.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Hair follicles could help develop eye treatments by studying immune responses.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

The microenvironment affects the behavior and survival of melanocytes with the GNAQ oncogene in melanoma.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

Genetic factors play a crucial role in the development of intervertebral disc herniation and protrusion.

Human skin models are essential for studying skin's sensory, immune, and nervous system interactions.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

New treatments for alopecia areata show promise in improving hair loss outcomes.

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

Mouse models help understand alopecia areata and find treatments.

Early exposure to germs may protect against autoimmune diseases, lack of sex increases alcohol preference in fruit flies, a potential baldness treatment could involve blocking a specific receptor, skin memory cells help prevent re-infection, high-fat diets can affect brain cells related to weight, and the link between social status, stress, and heart disease in primates is unclear.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.